Literature DB >> 18006561

Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation.

B C J M Fauser1, K Diedrich, P Devroey.   

Abstract

Ovarian stimulation is applied in the clinic to restore mono-ovulatory cycles in anovulatory women (ovulation induction) or to induce the development of multiple dominant follicles for assisted reproduction. Ovarian response is the endocrine and follicular reaction of the ovaries to stimulation. Achieving an appropriate ovarian response to anti-estrogens or exogenous gonadotrophins is central to ovulation induction and ovarian stimulation protocols. However, achieving an adequate response, without cycle cancellation or adverse events related to under- or over-stimulation, is complicated by high intra- and inter-individual variability. To predict each patient's ovarian response to medication for ovarian stimulation and to individualize the starting dose of exogenous gonadotrophin or the need for exogenous luteinizing hormone, various clinical, endocrine, ovarian ultrasonographic and genetic characteristics have been explored. Some of these features have been incorporated into prediction models. In this review, the methodology behind predictive factors and prediction models and their potential clinical applicability across ovulation induction and ovarian stimulation are explored.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18006561     DOI: 10.1093/humupd/dmm034

Source DB:  PubMed          Journal:  Hum Reprod Update        ISSN: 1355-4786            Impact factor:   15.610


  48 in total

1.  Developmental programming: contribution of prenatal androgen and estrogen to estradiol feedback systems and periovulatory hormonal dynamics in sheep.

Authors:  Almudena Veiga-Lopez; Olga I Astapova; Esther F Aizenberg; James S Lee; Vasantha Padmanabhan
Journal:  Biol Reprod       Date:  2009-01-02       Impact factor: 4.285

2.  Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles.

Authors:  Pelin Ocal; Sezai Sahmay; Meral Cetin; Tulay Irez; Onur Guralp; Ismail Cepni
Journal:  J Assist Reprod Genet       Date:  2011-09-01       Impact factor: 3.412

Review 3.  Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function.

Authors:  Livio Casarini; Elisa Pignatti; Manuela Simoni
Journal:  Rev Endocr Metab Disord       Date:  2011-12       Impact factor: 6.514

Review 4.  Cardiometabolic Risk in PCOS: More than a Reproductive Disorder.

Authors:  Laura C Torchen
Journal:  Curr Diab Rep       Date:  2017-11-11       Impact factor: 4.810

5.  Do estrogen receptor alpha polymorphisms have any impact on the outcome in an ART program?

Authors:  Elli Anagnostou; Fotodotis Malamas; Despina Mavrogianni; Vasiliki Dinopoulou; Peter Drakakis; Konstantinos Kallianidis; Dimitris Loutradis
Journal:  J Assist Reprod Genet       Date:  2013-03-15       Impact factor: 3.412

Review 6.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

7.  Demographic characteristics and clinical profile of poor responders in IVF / ICSI: A comparative study.

Authors:  Nabaneeta Padhy; Shalu Gupta; Asmita Mahla; M Latha; Thangam Varma
Journal:  J Hum Reprod Sci       Date:  2010-05

8.  Prestimulation parameters predicting live birth in anovulatory WHO Group II patients undergoing ovulation induction with gonadotrophins.

Authors:  A Nyboe Andersen; A H Balen; P Platteau; G Pettersson; J-C Arce
Journal:  Hum Reprod       Date:  2010-06-03       Impact factor: 6.918

Review 9.  Animal models of the polycystic ovary syndrome phenotype.

Authors:  Vasantha Padmanabhan; Almudena Veiga-Lopez
Journal:  Steroids       Date:  2013-05-20       Impact factor: 2.668

Review 10.  Approaches to improve the diagnosis and management of infertility.

Authors:  P Devroey; B C J M Fauser; K Diedrich
Journal:  Hum Reprod Update       Date:  2009-04-20       Impact factor: 15.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.